Drug Topics

JULY 18, 2025

The Evolving Landscape of Insulin Delivery in Diabetes Management Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 17th 2025 Podcast Amid increased advancements in diabetes management, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed how these developments are currently impacting the delivery of insulin.

Specialty Pharmacies

Drug Topics

JULY 15, 2025

READ MORE: Insulin Advancements Led to Safer Surgeries, Shorter Hospital Stays Drug Topics : How has the administration of insulin management been impacted by medical advancements in things like CGM and GLP-1 medications? Diana Isaacs: It's really interesting. Subscribe Now!

Insurance Coverage

Drug Topics

JULY 22, 2025

In a review earlier in 2025, it was estimated that adolescent obesity affects 21% of patients aged 12 to 18 years. January 30, 2025. Accessed July 21, 2025. GLP-1 Use Increased Significantly Among Pediatric Patients With T2D in Past 5 Years | ADA 2025. June 25, 2025. Accessed July 21, 2025. Drug Topics.

Specialty Pharmacies

Drug Topics

JUNE 18, 2025

In a session at the Pharmacy Quality Alliance Annual Meeting 2025, presenters stated that approximately 68% of patients have at least 1 unmet SDOH. The Mount Sinai Hospital. June 18, 2025. Accessed June 18, 2025. Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025. May 15, 2025.

Communication

Drug Topics

JUNE 6, 2025

2 Pharmacists can play a large role in the management of IBD, especially because medication nonadherence is common, leading to increased flares, hospitalizations, and complications. June 4, 2025. Accessed June 6, 2025. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Accessed June 6, 2025. Mayo Clinic.

FDA

Pharmacy Times

JULY 16, 2025

That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025.

Vaccines

The Checkup by Singlecare

MARCH 31, 2025

However, due to the shortage, compounding pharmacies and facilities were allowed to temporarily produce compounded semaglutide to meet the high demandeven though compounded semaglutide injections are not FDA approved. Some facilities add B12 to their compounds, in addition to semaglutide.

Compounding

Hospital Pharmacy Europe

JULY 23, 2025

However, in many clinical settings, including hospital wards, a prescribed tablet strength may not be available, or a patient might have difficulty swallowing solid oral dosage forms. For some, well-developed compounding services provide patient-specific doses within hours.

Hospitals

Pharmacy Times

JUNE 20, 2025

Furthermore, an investigation conducted by Norwalk et al found significant differences between Black and non-Black populations in pneumococcal mortality and length of hospital stay. Racial disparities in adult pneumococcal vaccination indications and pneumococcal hospitalizations in the US. J Natl Med Assoc. 2019;111(5):540-545.

Vaccines

Pharmacy Times

JULY 25, 2025

Accessed July 23, 2025. Accessed July 23, 2025. Public transit cuts during COVID-19 compound social vulnerability in 22 US cities. Pneumococcal disease­­—pneumococcal vaccine recommendations. Last Updated October 26, 2024. CDC—AdultVaxView. Last Updated October 4, 2024. Hong K, Zhou F, Tsai Y, et al. MMWR Morb Mortal Wkly Rep.

Vaccines

Hospital Pharmacy Europe

MARCH 18, 2025

Here, speaking to Gerry Hughes, she shares her insights on current clinical pharmacy challenges around expansion and integration of hospital pharmacists, and the exciting trajectory this branch of pharmacy is set to undertake in the years ahead. Over previous decades, there have been several inflection points in its progress.

Hospitals

Drug Topics

JUNE 23, 2025

Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.

Community Pharmacies

Drug Topics

JULY 29, 2025

1 The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 Image Credit: Jesse B/peopleimages.com - stock.adobe.com In the study, eligible patients from Denmark who previously had 3 or more COVID-19 doses received the 2024-2025 JN.1 The study took place from May 1, 2024, to March 31, 2025. 1 booster vaccination. .

Vaccines

Drug Topics

JULY 18, 2025

Hospitalization occurs in 1% to 4% of cases, mostly involving immunocompromised individuals. July 17, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. Accessed July 18, 2025. While most experience shingles only once, recurrence is possible. News Release. October 23, 2017.

Vaccines

Pharmacy Times

JULY 16, 2025

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, showcased significant advances across a range of malignancies, with novel agents, biomarker-driven strategies, and long-term outcomes data offering new insights into cancer treatment with implications for pharmacy practice.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 22, 2025

Importantly, Novavax received FDA approval in May 2025 with restrictions: It is approved for individuals 65 years and older and patients aged 12 to 64 years with at least 1 health condition that puts them at risk for severe COVID-19. If a patient has already received 1 dose, they are all set for the upcoming RSV season.

Vaccines

Pharmacy Times

JUNE 24, 2025

Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting.

Compounding Pharmacies

Pharmacy Times

JULY 22, 2025

Finerenone and the Future of Diabetes-Related Kidney Care Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Compounding Pharmacies

Drug Topics

JULY 17, 2025

1 “Eligible outcomes included changes in health-related quality of life, medication adherence, hospitalization rates, inhalation techniques, or disease-related knowledge." " Finally, pharmacist-led interventions were all conducted in community pharmacies, outpatient clinics, or hospital settings. 2025; [link] 2.

Specialty Pharmacies

Drug Topics

JUNE 19, 2025

Image Credit: WindyNight - stock.adobe.com "Our findings showed that adolescents who received this combination therapy were able to improve many symptoms typically associated with insulin-managed type one diabetes,” Farid Mahmud, MD, FRCPC, physician at The Hospital for Sick Children, said in a news release. June 17, 2025.

Compounding

Pharmacy Times

JULY 14, 2025

McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy. SHOW MORE Dave’s Pharmacy in Alliance, Nebraska, was named the Pharmacy of the Year for cutting-edge patient care.

Independent Pharmacies

Pharmacy Times

AUGUST 1, 2025

Accessed July 23, 2025. January 14, 2025. Accessed July 23, 2025. Accessed July 23, 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025.

Specialty Pharmacies

Pharmacy Times

JULY 2, 2025

The injection's room-temperature stability and compatibility with automated dispensing cabinets facilitate integration into hospital workflows. The study authors noted that sepsis is also a leading cause of death and hospitalization that often requires antibiotic administration.

FDA

Pharmacy Times

JULY 12, 2025

At McKesson ideaShare 2025, pharmacy leaders spotlighted the growing role of pharmacists in expanding clinical services, including telehealth, contraception prescribing, naloxone access, and point-of-care testing (POCT). SHOW MORE Pharmacy-based clinical services demonstrate both public health impact and financial sustainability.

Independent Pharmacies

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? Related Videos Related Content Advertisement June 20th 2025 Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy Kelley D. Sessions : Oncology Pharmacists Connect—this is the third year, right?

Compounding Pharmacies

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).

Compounding Pharmacies

Pharmacy Times

JULY 22, 2025

2 In April 2025, the FDA announced its plan to phase out the animal testing requirements and require new approach methodologies (NAMs) in early research to streamline which treatments will be safe and effective in humans, reduce drug development costs and timelines, and reduce testing in animals.

FDA

Pharmacy Times

JULY 22, 2025

Compounding this issue, many pharmacies face ongoing staffing shortages, which hinder efficient operations and compromise the ability to deliver quality patient care. Furthermore, delays in medication access can exacerbate chronic conditions, such as diabetes, hypertension, and asthma, leading to increased hospitalization rates.

Mail-Order Pharmacies

Pharmaceutical Technology

JULY 30, 2025

July 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook MP1032 is intended for treating Duchenne muscular dystrophy. MetrioPharm’s lead compound, MP1032, has received orphan drug designation (ODD) from the European Medicines Agency (EMA) for treating Duchenne muscular dystrophy (DMD) in children.

Packaging

Drug Topics

JULY 7, 2025

Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Although sodium-glucose cotransporter 2 inhibitors (SGLT2i)-induced erythrocytosis is prevalent, investigators found that it was not associated with thrombotic risk, according to results of a study published in JAMA Network Open. g/dL in hemoglobin and a 1.4% Available from: [link] 3.

Compounding

Pharmacy Times

JULY 26, 2025

Accessed June 4, 2025. Accessed June 4, 2025. Updated February 15, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. REFERENCES Rivaroxaban. MedlinePlus. Updated April 15, 2023. link] Edoxaban.

Compounding Pharmacies

Pharmacy Times

JULY 25, 2025

John’s University – College of Pharmacy and Health Sciences and practices as an infectious diseases pharmacist at NYC Health + Hospitals/Elmhurst in Elmhurst, New York. Accessed March 2, 2025. Accessed March 5, 2025. Accessed March 5, 2025. Clinical and Laboratory Standards Institute; 2025. Cephalexin. Lexi-Drugs.

HIV Treatment and Prevention Agents

Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations.

Compounding Pharmacies

Pharmacy Times

JULY 21, 2025

Accessed June 17, 2025. Updated February 2025. Accessed June 17, 2025. Related Videos Related Content Advertisement July 21st 2025 Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Tori L. Health Sci Rep. 2025;8(4):e70747. doi:10.1002/hsr2.70747 Continuous glucose monitors. link] Miller EM.

Compounding Pharmacies

Pharmacy Times

JUNE 27, 2025

On January 16, 2025, the FDA approved acalabrutinib (Calquence; AstraZeneca) in combination with bendamustine and rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ineligible for autologous hematopoietic stem cell transplantation (HSCT). January 16, 2025. Cancer Treat Rev.

FDA

Pharmacy Times

JUNE 20, 2025

American Pharmaceutical Association; 2025. Accessed April 28, 2025. Accessed April 28, 2025. Terrie, BSPharm, RPh Key Takeaways Dysmenorrhea affects 50% to 90% of females, causing absenteeism and reduced quality of life, with primary and secondary types identified. Dysmenorrhea and endometriosis in the adolescent. December 2018.

Compounding Pharmacies

Pharmacy Times

JUNE 9, 2025

These conclusions were presented as part of an abstract from the open-label, phase 3 CheckMate 816 trial (NCT02998528) at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, and subsequently published in the Journal of Clinical Oncology. J Clin Oncol. 2025;43(17). doi:10.1200/JCO.2025.43.17_suppl.LBA800.

Chemotherapy